Apparent plasticity in the biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
Roland Seiler(University of British Columbia), Peter C. Black(University of British Columbia), Hung‐Ming Lam(Seattle Pacific University), Mandeep Takhar(Genome British Columbia), Ewan A. Gibb(BC Cancer Agency), George N. Thalmann(University Hospital of Bern), Ellen C. Zwarthoff(Erasmus MC), Nicholas Erho(Genome British Columbia), Htoo Zarni Oo(University of British Columbia), Kim E.M. van Kessel(Erasmus University Rotterdam), Gottfrid Sjödahl(Lund University), Joost L. Boormans(Erasmus MC), Jonathan L. Wright(Seattle University), Marc Dall’Era(University of California, Davis), Natalie Qiqi Wang(Genome British Columbia), Michiel Simon Van Der Heijden(The Netherlands Cancer Institute), Brian Winters(University of Washington), James J. Douglas, Bas W.G. van Rhijn(The Netherlands Cancer Institute), Elai Davicioni(Coherus BioSciences (United States))
Cited by 0
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
|European Urology|2020|2.2k
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
|Cancer Cell|2017|2.1k
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k